search for books and compare prices
Tables of Contents for Mitochondrial Disorders
Chapter/Section Title
Page #
Page Count
Introduction
1
4
G. Serratrice
Mitochondrial Biology
The Mitochondrial Machinery
5
12
S. Di Donato
Mitochondria in Neurodegeneration
17
20
M.F. Beal
Apoptosis and Oxidative Stress in Mitochondrial Disorders
37
10
S. Servidei
S. Di Giovanni
A. Broccolini
A. D'Amico
M. Mirabella
G. Silvestri
Mitochondria and Ageing
47
12
D.M. Turnbull
M.J. Barron
Cardiac Mitochondrial Dysfunction in Aging and in Ischemia/Reperfusion. Role of Oxygen Free radicals and Cardiolipin
59
12
G. Paradies
G. Petrosillo
F.M. Ruggiero
Deregulation of Mitochondrial Apoptosis in Cancer
71
20
G. Peluso
O. Petillo
S. Margarucci
A. Calarco
M. Calvani
Iatrogenic Mitochondrial Diseases
Drug induced Hepatotoxicity and Mitochondrial Dysfunction
91
16
B. Fromenty
C. Maisonneuve
R. Note
A. Berson
D. Pessayre
The Carnitine System Involvement in Mitochondrial Pharmacologic Sensitivity
107
24
M. Calvani
P. Benatti
R. Nicolai
E. Reda
Mitochondrial Toxicity of Anti-Retroviral Drugs
131
10
K. Brinkman
Mitochondrial Damage in HIV Patients treated with Highly Active Anti-retroviral Therapy
141
12
A. Lombes
C. Barthelemy
C. Jardel
E. Teicher
T. Maisonobe
D. Vittecoq
Hyperlactatemia and HIV-infected Patients with Nucleoside Analog Reverse- transcriptase Inhibitors Treatment: the Clermont HIV Cohort Study
153
8
V. Sapin
G. Marceau
C. Jacomet
C. Boniol
L. Cormerai
H. Laurichesse
B. Dastugue
J. Beytout
O. Boespflug-Tanguy
Severe Lactic Acidosis and Multiple Organ Failure in HIV Patients treated with Nucleoside Analogues reverse Transcriptase Inhibitors: a Pilot Study of Treatment with L-Carnitine
161
12
Y.E. Claessens
A. Cariou
Mitochondrial Dysfunction in Perinatal Exposure to Antiretroviral Nucleoside Analogues
173
10
M. Tardieu
P. Rustin
M.J. Mayaux
S. Blanche
Mitochondrial Myopathy in Non-Infected New-Born from HIV-1 Mothers treated with Antiretroviral Drugs
183
10
N.B. Romero
C. Lacroix
J.F. Pellissier
Mitochondrial Medicine
Neurological Features of Genetic and Acquired Metabolic Mitochondrial Defects
193
18
C. Desnuelle
C. Richelme
V. Paquis-Flucklinger
Clinical Heterogeneity associated to Dysfunction of Mitochondrial DNA: the example of the 3243 ``MELAS'' Mutation
211
10
V. Paquis-Flucklinger
Inborn and Acquired Mitochondrial Leucodystrophy
221
10
B. Chabrol
C. Raybaud
Mitochondrial Dysfunction, Epilepsy, and Antiepileptic drugs
231
16
D.C. De Vivo
D. Nordli
S. DiMauro
Friedreich Ataxia as an Example of the Dual Genome Control of Mitochondrial Function
247
8
P. Rustin
V. Geromel
N. Darin
A. Munnich
A. Rotig
How wide are Mitochondria involved in Exercise Intolerance?
255
10
J. Arenas
Y. Campos
M.A. Martin
S. DiMauro
A.L. Andreu
Mitochondrial Defects in Myositis and Inclusion Body Myopathies
265
10
A. Oldfors
Mitochondrial Dysfunction and the Gastrointestinal System
275
12
L. Bindoff
Mitochondrial Diabetes: Clinical Specificity and Diagnosis
287
8
B. Vialettes
H. Narbonne
Mitochondrial Featuring in Kidney Disorders and Myelodysplastic Syndromes
295
12
O. Benveniste
S. Herson
Treatment
Treatment of Mitochondrial Diseases
307
 
S. DiMauro